You need to enable JavaScript to run this app.
ICH adopts M15 guideline on model-informed drug development
Regulatory News
Joanne S. Eglovitch
Global
ICH
Modeling and simulation
Pharmaceuticals
Product development
Regulatory Intelligence/Policy